Phase II Trial Launches (IMAGE)
Caption
Patient Melvin Dyess, far right, participates in phase II of a stem cell trial at the University of Texas Medical School at Houston, where Dr. Ali Denktas, center, is the lead investigator.
Credit
Deborah Mann Lake
Usage Restrictions
None
License
Licensed content